ENTA icon

Enanta Pharmaceuticals

144 hedge funds and large institutions have $805M invested in Enanta Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 64 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 146144 (-2)

7% less capital invested

Capital invested by funds: $869M → $805M (-$63.9M)

33% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 64

Holders
144
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.12M
Puts
$440K
Net Calls
Net Calls Change

Top Buyers

1 +$28.8M
2 +$8M
3 +$7.89M
4
Citadel Advisors
Citadel Advisors
Florida
+$7.32M
5
Bank of America
Bank of America
North Carolina
+$6.77M

Top Sellers

1 -$12.6M
2 -$5.85M
3 -$5.12M
4
TCM
Tang Capital Management
California
-$4.45M
5
Norges Bank
Norges Bank
Norway
-$4.2M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$153M
2
$81.4M
3
$62.7M
4
$62.2M
5
$48.6M
6
$42M
7
$34.9M
8
$24.4M
9
$21.8M
10
$17.3M
11
$16M
12
$14M
13
$12.2M
14
$11.8M
15
$11.7M
16
$11M
17
$10.7M
18
$9.3M
19
$9.01M
20
$8.79M
21
$6.78M
22
$6.76M
23
$6.58M
24
$6.01M
25
$5.69M